GLX351322

GLX351322
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T8107-2mg 2 mg

7 - 10 business days*

42.00€
TGM-T8107-5mg 5 mg

7 - 10 business days*

67.00€
TGM-T8107-10mg 10 mg

7 - 10 business days*

112.00€
TGM-T8107-1mL 1 ml

7 - 10 business days*

133.00€
TGM-T8107-25mg 25 mg

7 - 10 business days*

253.00€
TGM-T8107-50mg 50 mg

7 - 10 business days*

434.00€
TGM-T8107-100mg 100 mg

7 - 10 business days*

645.00€
 
Description: GLX351322 is NADPH Oxidase 4 Inhibitor with IC50 of 5 µM. Target:... more
Product information "GLX351322"
Description: GLX351322 is NADPH Oxidase 4 Inhibitor with IC50 of 5 µM. Target: NADPH, NADPH-oxidase. Smiles: CCOC(=O)c1c(NC(=O)CN2CCN(CC2)C(=O)c2ccco2)sc2CCCc12. References: Anvari, Ebrahim, Wikström, Per, Walum, Erik,et al. The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL/6 mice[J]. Free Radical Research, 49(11):1-32.
Supplier: TargetMol
Supplier-Nr: T8107

Properties

Application: NOX4 inhibitor
MW: 431.51 D
Formula: C21H25N3O5S

Database Information

CAS : 835598-94-2| Matching products
KEGG ID : K21423 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "GLX351322"
Write a review
or to review a product.
Viewed